type 1 diabetes mellitus 6
MONDO:0011167
An inherited susceptibility or predisposition to developing type 1 diabetes mellitus that has material basis in mutation of the locus at chromosome 18q21.
Disease research snapshot
No clinical trials have been linked to this exact normalized concept in the current published dataset. This is a coverage limitation, not evidence that the condition or medicine has never been studied. Try a synonym or browse registry-reported labels.
Numbers are derived from CureCurrent's current ClinicalTrials.gov projection and conservative MONDO/RxNorm mappings. See sources, counting rules and limitations and verify eligibility or clinical findings with the original study record.
How to interpret diabetes clinical trials
Diabetes studies can investigate glucose management, cardiovascular or kidney outcomes, devices, prevention, and long-term complications. Results from one population or diabetes subtype should not automatically be applied to another.
Which measures matter?
Look at each trial's prespecified primary outcome. HbA1c reflects average glucose levels over approximately two to three months; other studies may focus on time in range, hypoglycemia, adverse events, or disease-related complications. The primary outcome and follow-up period are essential for interpreting results.
Read eligibility and design carefully
Check whether a study concerns type 1 diabetes, type 2 diabetes, gestational diabetes, or a narrower population. Compare interventions, control groups, enrollment criteria, and how long participants are followed. A recruiting status is not evidence of safety or effectiveness.
About CureCurrent's research counts
These are trial registry records linked to the mapped disease concept; they are not a measure of proven treatment options. Check linked ClinicalTrials.gov records for current enrollment and original study details.
Source: ClinicalTrials.gov. Terminology: MONDO. This material is educational, not personalized medical advice.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
MONDO disease family
Recruiting studies by city
Trial status
Trial phase
Study start year
Investigated drug interventions
type 1 diabetes mellitus 6
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.